SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced its new Residual Acute Myeloid (RAM) Application. The new offering expands the company’s...